Good afternoon and welcome to the BioCardia year-end 2024 financial results and business update conference call. (Operator Instructions) A webcast replay of the call will be available approximately ...

Q4 2024 Earnings Call Transcript March 31, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.54, ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

A fast-paced packaging symposium held in Melbourne last week, brought together some of the industry leading minds to share up ...

Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsJennifer Williams - Investor and ...

The incidence of sudden cardiac arrest during marathons and half-marathons remained relatively stable over the past 2 decades ...

Lynch Regenerative Medicine, LLC., (LRM) announced today that it has acquired exclusive rights to REGRANEX® gel and recombinant purified platelet-derived growth factor (PDGF) from Smith & Nephew, Inc.

A Stanford University study presented at the American College of Cardiology’s annual session finds no significant differences ...

Three physicists, an assistant GM and a player try to answer the one big question that every Orioles fan has asked.

The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...